These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3256857)

  • 21. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL
    Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract]   [Full Text] [Related]  

  • 22. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland.
    Paunio M; Virtanen M; Peltola H; Cantell K; Paunio P; Valle M; Karanko V; Heinonen OP
    Am J Epidemiol; 1991 Jun; 133(11):1152-60. PubMed ID: 2035518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Side effects of the use of the preventive mixed mumps, rubella and measles vaccine inchildren of the City of São Paulo].
    Konichi SR; Laus WC; Mattos CA; Amato Neto V; Aly J; Finger H; Bianchi A
    Rev Inst Med Trop Sao Paulo; 1973; 15(3):161-4. PubMed ID: 4732747
    [No Abstract]   [Full Text] [Related]  

  • 25. Rates of first measles-mumps-rubella immunisation in Wales (UK).
    Thomas DR; Salmon RL; King J
    Lancet; 1998 Jun; 351(9120):1927. PubMed ID: 9654262
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of a trivalent combined vaccine against measles, parotiditis and rubella].
    Randall AG; Leonard JM
    Salud Publica Mex; 1971; 13(3):313-7. PubMed ID: 5164661
    [No Abstract]   [Full Text] [Related]  

  • 28. Expanded programme on immunization. Immunization coverage against measles, mumps and rubella.
    Wkly Epidemiol Rec; 1993 Mar; 68(12):83-6. PubMed ID: 8452784
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatitis caused by measles, mumps, and rubella vaccine.
    Adler JB; Mazzotta SA; Barkin JS
    Pancreas; 1991 Jul; 6(4):489-90. PubMed ID: 1876605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision making for routine measles/MMR and whooping cough immunisation.
    Nicoll A; Jenkinson D
    BMJ; 1988 Aug; 297(6645):405-7. PubMed ID: 3408985
    [No Abstract]   [Full Text] [Related]  

  • 34. Measles lessons learned.
    Scott G
    Nurs Stand; 1996 Jul; 10(44):13. PubMed ID: 8850749
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vaccination against measles, mumps and rubella--together or separately?].
    Vesikari T; Elo O
    Duodecim; 1979; 95(9):527-9. PubMed ID: 544244
    [No Abstract]   [Full Text] [Related]  

  • 36. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
    Stokes J; Weibel RE; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 Oct; 218(1):57-61. PubMed ID: 4937795
    [No Abstract]   [Full Text] [Related]  

  • 37. Mumps incidence in Israel--impact of MMR vaccine.
    Slater PE; Roitman M; Costin C
    Public Health Rev; 1990-1991; 18(1):88-93. PubMed ID: 2132885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mumps and rubella consensus conference.
    Can Commun Dis Rep; 1994 Oct; 20(19):165-76. PubMed ID: 7804152
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS; Stracener CE; Bass JW
    JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [1st results with a combined live vaccine against measles, mumps, and rubella].
    Stehr K; Epp C; Spiess H
    Monatsschr Kinderheilkd (1902); 1975 May; 123(5):410-2. PubMed ID: 1219453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.